<?xml version="1.0" encoding="UTF-8"?>
<ref id="B147-cancers-13-02036">
 <label>147.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Schoenfeld</surname>
    <given-names>J.D.</given-names>
   </name>
   <name>
    <surname>Sibenaller</surname>
    <given-names>Z.A.</given-names>
   </name>
   <name>
    <surname>Mapuskar</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Wagner</surname>
    <given-names>B.A.</given-names>
   </name>
   <name>
    <surname>Cramer-Morales</surname>
    <given-names>K.L.</given-names>
   </name>
   <name>
    <surname>Furqan</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sandhu</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Carlisle</surname>
    <given-names>T.L.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Hejleh</surname>
    <given-names>T.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>O
   <sub>2</sub>
   <sup>âˆ’</sup> and H
   <sub>2</sub>O
   <sub>2</sub>-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate
  </article-title>
  <source>Cancer Cell</source>
  <year>2017</year>
  <volume>31</volume>
  <fpage>487</fpage>
  <lpage>500</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ccell.2017.02.018</pub-id>
  <?supplied-pmid 28366679?>
  <pub-id pub-id-type="pmid">28366679</pub-id>
 </element-citation>
</ref>
